Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Bartłomiej Zagożdżon"'
Autor:
Łukasz Nyk, Hubert Kamecki, Bartłomiej Zagożdżon, Andrzej Tokarczyk, Piotr Baranek, Łukasz Mielczarek, Piotr Kryst, Sławomir Poletajew, Roman Sosnowski, Stanisław Szempliński
Publikováno v:
Current Oncology, Vol 29, Iss 4, Pp 2768-2775 (2022)
We aimed to assess whether the ongoing course of the COVID-19 epidemic has been associated with an increased risk of adverse pathology (AP) findings in prostate cancer (PC) patients treated with radical prostatectomy (RP). We performed a retrospectiv
Externí odkaz:
https://doaj.org/article/518082d3f5794334854db866c8c771bc
Publikováno v:
Videosurgery and Other Miniinvasive Techniques, Vol 14, Iss 2, Pp 262-270 (2019)
Externí odkaz:
https://doaj.org/article/43a7b1d684584e73a5460041373c7ab4
Autor:
Łukasz Nyk, Wojciech Michalak, Stanisław Szempliński, Rafał Woźniak, Bartłomiej Zagożdżon, Wojciech Krajewski, Piotr Kryst, Hubert Kamecki, Sławomir Poletajew
Publikováno v:
Journal of Personalized Medicine; Volume 12; Issue 2; Pages: 251
To compare oncological and functional outcomes of high-intensity focused-ultrasound (HIFU) focal therapy (FT) versus laparoscopic radical prostatectomy (LRP) in patients treated for low- or intermediate-risk prostate cancer (PCa), we retrospectively
Autor:
Stanisław Szempliński, Hubert Kamecki, Małgorzata Dębowska, Bartłomiej Zagożdżon, Mateusz Mokrzyś, Marek Zawadzki, Roman Sosnowski, Andrzej Tokarczyk, Sławomir Poletajew, Piotr Kryst, Łukasz Nyk
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 1; Pages: 156
Prostate biopsy is recommended in cases of positive magnetic resonance imaging (MRI), defined as Prostate Imaging Reporting and Data System (PIRADS) category ≥ 3. However, most men with positive MRIs will not be diagnosed with clinically significan